Digital Health Technologies are Reshaping the Future of Healthcare

 

The healthcare landscape is seeing very constant and swift changes with the integration of digital technologies — a trend that’s been accelerated by the ongoing need to enhance patient outcomes and improve access to care. The conversation around digital health is timely, as the general health industry witnesses significant advancements in telemedicine, remote patient monitoring, and personalized medicine. According to a recent report, the global digital health market is projected to reach a value of $430 billion by 2028, reflecting the immense potential and growth of these technologies.

What are the key innovations shaping the future of healthcare, and how can stakeholders work together to ensure equitable access to these advancements?

For the newest segment of “Highway to Health,” host David Kemp, led about the transformative power of digital health with special guest Dr. Liz Kwo, Chief Medical Officer at Everly Health. The episode also explored the dynamic changes in healthcare technology, the importance of stakeholder alignment, and strategies for scaling digital health innovations effectively.

A few other key points of their discussion covered:

  • The role of computational power and integrated data models in accelerating healthcare innovations.
  • Strategies for aligning payers, providers, and patients to adopt new technologies and improve care delivery.
  • The potential of digital health technologies like AI, remote monitoring, and pharmacogenomics in enhancing patient care.

Dr. Liz Kwo currently serves as the Chief Medical Officer at Everly Health. She is a multi-faceted leader in the healthcare industry with a background as a physician, entrepreneur, and innovator. Dr. Kwo has a wealth of experience in clinical practice and healthcare technology. She has been instrumental in developing and scaling digital health solutions, focusing on improving patient outcomes and expanding access to care. Her expertise spans across various domains, including genomics, digital health strategy, and health policy.

Article by Alexandra Simon.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…